Nanjing IASO Biotherapeutics announced that it has raised funds in a round of funding on January 13, 2023. The transaction included participation from new investors, Shanghai Chuanghehui Investment Management Co., Ltd. and Jointown Pharmaceutical Group Co., Ltd.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.698 CNY | +1.10% | -1.08% | +4.85% |
Apr. 29 | Jointown Pharma's Q1 Profit, Revenue Fall 4% | MT |
Apr. 29 | Jointown Pharmaceutical Group's 2023 Profit Jumps 4% | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.85% | 3.82B | |
+26.60% | 75.34B | |
-1.98% | 23.86B | |
+10.02% | 8.61B | |
+10.22% | 8.52B | |
-22.96% | 7.78B | |
+12.33% | 5.18B | |
+2.96% | 4.13B | |
-5.61% | 4.03B | |
+1.09% | 3.09B |
- Stock Market
- Equities
- 600998 Stock
- News Jointown Pharmaceutical Group Co., Ltd
- Nanjing IASO Biotherapeutics announced that it has received funding from Shanghai Chuanghehui Investment Management Co., Ltd., Jointown Pharmaceutical Group Co., Ltd